No Connection between Long-Term Lithium Treatment and Antithyroid Antibodies

Abstract

Introduction The studies on the effect of lithium treatment on antithyroid antibodies showed either a higher concentration of these antibodies in patients receiving lithium compared to those lithium-naive or no difference between these groups. In lithium-treated bipolar patients, some researchers pointed to an association between antithyroid antibodies and other features of thyroid dysfunction such as hypothyroidism and decrease of glomerular filtration rate.

Methods We compared antithyroid antibodies in 98 patients (30 male, 68 female) with bipolar disorder, aged 62±13 years, who received lithium for 19±10 years to 39 patients (12 male, 27 female), aged 57±10 years, who were never treated with lithium. The antibodies against thyroid peroxidase (TPOAb), against thyroglobulin (TGAb), and thyroid-stimulating hormone (TSH) receptors (TSHRAb) were estimated.

Results No difference in the percentages of antibodies occurrence was found between groups, although the concentrations of TGAb were higher in patients receiving lithium. In lithium-treated patients, the presence of TPOAb was associated with lower concentrations of free triiodothyronine and the presence of TGAb, with higher concentrations of TSH. In females, the levels of TGAb were associated with lower thyroid volume. The concentrations of TPOAb correlated positively with the duration of lithium therapy in males, and those of TPOAb and TGAb negatively, with such duration, in female patients.

Conclusion The results obtained showed no significant connection between long-term lithium treatment and antithyroid antibodies. In bipolar patients receiving lithium longitudinally, antithyroid antibodies can be associated with some indexes of thyroid function. However, they behave differently in male and female patients.

Key words

bipolar disorder - lithium - antithyroid antibodies

• References

• 1 Bocchetta A, Traccis F, Mosca E. et al. Bipolar disorder and antithyroid antibodies: review and case series. Int J Bipolar Disord 2016; 4: 5
• 2 Kupka RW, Nolen WA, Post RM. et al. High rate of autoimmune thyroiditis in bipolar disorder: Lack of association with lithium exposure. Biol Psychiatry 2002; 51: 305-311
• 3 Vonk R, van der Schot AC, Kahn RS. et al. Is autoimmune thyroiditis part of the genetic vulnerability (or an endophenotype) for bipolar disorder?. Biol Psychiatry 2007; 62: 135-140
• 4 Cobo J, Giménez-Palop O, Patró E. et al. Lack of confirmation of thyroid endophenotype in Bipolar Disorder Type I and their first-degree relatives. Psychoneuroendocrinology 2015; 51: 351-364
• 5 Chan AO, Iu YP, Shek CC. The reference interval of thyroid-stimulating hormone in Hong Kong Chinese. J Clin Pathol 2011; 64: 433-436
• 6 Schou M, Amdisen A, Eskjaer Jensen S. et al. Occurrence of goitre during lithium treatment. Br Med J 1968; 3: 710-713
• 7 Wilson R, McKillop JH, Crocket GT. et al. The effect of lithium therapy on parameters thought to be involved in the development of autoimmune thyroid disease. Clin Endocrinol 1991; 34: 357-361
• 8 Van Melick EJ, Wilting I, Meinders AE. et al. Prevalence and determinants of thyroid disorders in elderly patients with affective disorders: Lithium and nonlithium patients. Am J Geriatr Psychiatry 2010; 18: 395-403
• 9 Baethge C, Blumentritt H, Berghöfer A. et al. Long term lithium treatment and thyroid antibodies: A controlled study. J Psychiatry Neurosci 2005; 30: 423-427
• 10 Bocchetta A, Cocco F, Velluzzi F. et al. Fifteen-year follow-up of thyroid function in lithium patients. J Endocr Invest 2007; 30: 363-366
• 11 Bocchetta A, Ambrosiani L, Baggiani G. et al. Circulating antithyroid antibodies contribute to the decrease of glomerular filtration rate in lithium-treated patients: A longitudinal study. Int J Bipolar Disord 2018; 6: 3
• 12 First MB, Spitzer RL, Gibbon M. et al. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCIDCV). Washington, DC: American Psychiatric Press Inc; 1996
• 13 Kraszewska A. [The effect of long-term lithium treatment on thyroid function in patients with bipolar affective illness]. Thesis. Poznan University of Medical Sciences 2018
• 14 Bauer M, Glenn T, Pilhatsch M. et al. Gender differences in thyroid system function: Relevance to bipolar disorder and its treatment. Bipolar Disord 2014; 16: 58-71
• 15 Ferensztajn-Rochowiak E, Kaczmarek M, Wójcicka M et al. Glutamaterelated antibodies and peripheral insulin-like growth factor in bipolar disorder and lithium prophylaxis. Neuropsychobiology 2018 Oct 18 [Epub ahead of print]
• 16 Ferensztajn-Rochowiak E, Kucharska-Mazur J, Tarnowski M. et al. Stem cells, pluripotency and glial cell markers in peripheral blood of bipolar patients on long-term lithium treatment. Prog Neuropsychopharmacol Biol Psychiatry 2018; 80: 28-33